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Background: Women in the menopausal transition and the postmenopausal period are affected with vasomotor
symptoms, urogenital atrophy, sexual dysfunction, somatic symptoms, cognitive difficulty, sleep disturbance, and
psychological problems. It is important to gain a better understanding of the complexity and diversity of climacteric
disturbance in order to optimize treatments for individual patients. The aim of this study was to identify subgroups
of Japanese perimenopausal and postmenopausal women attending a menopause clinic based on their physical
and psychological symptom profiles.
Methods: We administered the Menopausal Health-Related Quality of Life questionnaire to 491 Japanese women
aged 40–64 years who had enrolled in the Systematic Health and Nutrition Education Program at the Menopause
Clinic of the Tokyo Medical and Dental University Hospital between 2005 and 2012. We performed a principal
component analysis followed by a hierarchical cluster analysis of the responses to 9 physical and 12 psychological
items on the questionnaire.
Results: The first analysis extracted 3 principal components that defined the variance of physical and psychological
symptom profiles: depression, somatic, and vasomotor/sleep. A subsequent cluster analysis was performed based
on the 3 principal components to generate 4 clusters, CL8 (N = 162; 33.0%), CL6 (N = 111; 22.6%), CL5 (N = 102;
20.8%), and CL4 (N = 116; 23.6%). CL8 included women who only had mild-to-moderate musculoskeletal pains
and tiredness. All women in CL6, CL5, and CL4 described their musculoskeletal pains and tiredness as moderate
to severe. The women in CL5 also had moderate-to-severe vasomotor symptoms, while the women in CL4 also
suffered from moderate-to-severe psychological symptoms, such as depression, anxiety, and insomnia.
Conclusions: Distinct subgroups of Japanese perimenopausal and postmenopausal women were identified based
on their symptom profiles. Menopausal symptoms were shown to accumulate in this population in the order of
musculoskeletal pains and tiredness, vasomotor symptoms, and psychological symptoms.
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Table 1 Physical and mental health domain items in the









(none) (mild) (moderate) (severe)
Physical health domain
Nausea 0 1 2 3
Dizziness 0 1 2 3
Numbness 0 1 2 3
Muscle and joint
pains
0 1 2 3
Tiredness 0 1 2 3
Headaches 0 1 2 3
Frequent urination 0 1 2 3
Hot flush 0 1 2 3
Night sweats 0 1 2 3
Mental health domain
Loss of interest in
things
0 1 2 3
Lack of enjoyment 0 1 2 3
Low energy 0 1 2 3
Depressed mood 0 1 2 3
Poor memory 0 1 2 3
Difficulty in
concentration
0 1 2 3
Frightened/panicky
feelings
0 1 2 3
Feel tense/wound up 0 1 2 3
Dissatisfaction with
sexual relationship
0 1 2 3
Difficulty in
initiating sleep
0 1 2 3
Non-restorative
sleep
0 1 2 3
Low self-esteem 0 1 2 3
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Women in the menopausal transition and the postmeno-
pausal period are affected with vasomotor symptoms,
urogenital atrophy, sexual dysfunction, somatic symp-
toms, cognitive difficulty, sleep disturbance, and psycho-
logical problems. Some of these effects, particularly
vasomotor symptoms and urogenital atrophy, are closely
associated with estrogen deficiency, whereas the exact
mechanism underlying the other symptoms is not fully
understood.
Therefore, it is important to gain a better understand-
ing of the complexity and diversity of climacteric dis-
turbance in order to optimize treatments for individual
patients. Accordingly, previous trials have categorized
menopausal symptoms of non-menopause clinic samples
[1] and population-based samples [2-8], and identified
subgroups of menopausal women on the basis of their
responses to symptom checklists. Yet, subgrouping of
menopause clinic samples, which would be most rele-
vant to clinical practice, has not been reported.
The aim of the present study was to identify subgroups
of Japanese perimenopausal and postmenopausal women
attending a menopause clinic based on their physical
and psychological symptom profiles.
Methods
In this cross-sectional study, we examined the medical
records of a study population similar to that analyzed in
our previous studies [9-15]. Specifically, we retrospect-
ively analyzed the first-visit records of 491 Japanese peri-
menopausal and postmenopausal women aged 40–64
years who had enrolled in the Systematic Health and
Nutrition Education Program conducted at the Meno-
pause Clinic of the Tokyo Medical and Dental University
Hospital between 2005 and 2012. All middle-aged
women who had enrolled in this program were referred
to our clinic for the treatment of their menopausal
symptoms, and all participants provided informed con-
sent. Before beginning our investigation, we obtained ap-
proval for the study protocol from the Tokyo Medical
and Dental University Review Board and confirmed that
all participants provided informed consent. We ensured
that all study procedures were implemented in accord-
ance with the Declaration of Helsinki.
A woman was defined as being in the menopausal tran-
sition if she menstruated within the past 12 months but
had either missed a period or had experienced irregular
cycles in the past 3 months; a woman was defined as being
postmenopausal if she had not menstruated in the past
12 months [16]. At their initial visit, women were inter-
viewed by physicians and nutritionists, and they provided
data regarding their menopausal symptoms and quality of
life during the past month by completing the Menopausal
Health-Related Quality of Life questionnaire, which wedeveloped and validated at our clinic [9-15,17]. The
Menopausal Health-Related Quality of Life questionnaire
is a modification of the Women’s Health Questionnaire
developed by Hunter et al. and contains 38 items scored
on a 4-point or binary scale covering 4 major domains
(physical health, mental health, life satisfaction, and social
involvement) of a woman’s health during the menopausal
transition [1,18].
The items used to assess the 2 domains of interest in
the current study, physical health and mental health, are
shown in Table 1. The physical health domain comprised
9 items that assessed somatic and vasomotor symptoms,
and the mental health domain comprised 12 items that
assessed depressed mood, cognitive difficulties, anxiety
and fears, sexual functioning, and sleep problems. For
convenience, the scoring system shown in Table 1 is in
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tionnaire in our clinical practice; higher scores indicate
worse physical and mental functioning.
The symptom score profiles of participants were sub-
jected to a principal component analysis (PCA) to exam-
ine the relationships among the 21 physical and mental
symptoms and to define factors (principal components
[PCs]), composed of scores of related symptoms, that
could account for most of the variance in profiles of symp-
tom scores. The appropriate number of PCs was deter-
mined from the point on the Scree plot where eigenvalues
leveled off. PC values for each woman were then calcu-
lated based on the formulas obtained from the PCA.
Subsequently, a hierarchical cluster analysis was per-
formed using Ward’s minimum variance technique to sub-
group women based on the Euclidean distances among
the PC values.
All statistical analyses were performed with SAS 9.2
(SAS Institute, Cary, NC, USA). P <0.05 was defined as
statistically significant.
Results
A total of 491 women were included in the study, and
the mean ± standard deviation age of participants was
51.8 ± 5.4 years; 44% of participants were classified as
being in the menopausal transition, and 56% were classi-
fied as postmenopausal. The eigenvalues, percent of
variance, and factor loading (eigenvectors) obtained from
the initial PCA of study participants’ symptom score
profiles are shown in Table 2. Three PCs were identified,
accounting for 48% of variance. The first PC (PC1)
accounted for 32.8% of variance, for which the 3 symp-
tom scores with largest eigenvectors were low energy,Table 2 Principal component analysis
Eigenvalue % of variance Eigenvector




Lack of enjoyment 0.302
Principal component 2: 1.91 9.1
“somatic”
Dizziness 0.371
Muscle and joint pains 0.320
Nausea 0.318
Principal component 3: 1.28 6.1
“vasomotor/sleep”
Night sweats 0.434
Difficulty in initiating sleep 0.318
Hot flush 0.317depressed mood, and lack of enjoyment. Therefore, PC1
was best characterized as the component for “depres-
sion”. Likewise, PC2, accounting for 9.1% of variance,
was characterized as “somatic” because its top 3 symp-
toms were dizziness, muscle and joint pain, and nausea.
PC3, which accounted for 6.1% of variance, was charac-
terized as “vasomotor/sleep”, as symptoms included
night sweats, difficulty in initiating sleep, and hot flush.
Based on the PCA, PC1, 2, and 3 for each woman was
calculated as follows:
PC1 ¼ 0:321  “low energy” score þ
0:318  “depressed mood” score þ
0:302  “lack of enjoyment” score
PC2 ¼ 0:371  “dizziness” score þ
0:320  “muscle and joint pains” score þ
0:318  “nausea” score
PC3 ¼ 0:434  “night sweats” score þ
0:318  “difficulty in initiating sleep” score þ
0:317  “hot flush” score
Four distinct clusters (CLs) were obtained from the sub-
sequent cluster analysis based on the Euclidean distances
among the PC values: CL8 (N =162; 33.0%), CL6 (N = 111;
22.6%), CL5 (N = 102; 20.8%), and CL4 (N = 116; 23.6%)
(Figure 1).
Baseline physical characteristics of the study partici-
pants by cluster are shown in Table 3. One-way analysis
of variance and a chi-square test showed that height,
waist-hip ratio, systolic/diastolic pressure, pulse rate, and
the proportions of women who smoked and exercised
regularly differed among the groups. The average phys-
ical and psychological symptom scores of the 4 clusters
are shown in Table 4. The Kruskal-Wallis test showed
that scores for every item were significantly different
among the groups. On the basis of the average score for
each item, the 4 clusters were characterized as follows:
CL8 was composed of women who only had mild-to-
moderate muscle and joint pain and tiredness. All the
women in CL6, CL5, and CL4 assessed their musculo-
skeletal pains and tiredness as moderate to severe. The
women in CL5 also had moderate-to-severe vasomotor
symptoms, while the women in CL4 suffered from
moderate-to-severe psychological symptoms, such as de-
pression, anxiety, and insomnia.
Women with more severe symptoms tended to have
higher systolic/diastolic pressure, higher pulse rates,
smoked more, and exercised less frequently than women







Figure 1 Cluster analysis. Four distinct clusters (CLs) were obtained from the subsequent cluster analysis based on the Euclidean distances
among the PC values: CL8 (N = 162; 33.0%), CL6 (N = 111; 22.6%), CL5 (N = 102; 20.8%), and CL4 (N = 116; 23.6%).
Table 3 Baseline physical characteristics of the study participants (N = 491)
CL8 CL6 CL5 CL4 P
(N = 162) (N = 111) (N = 102) (N = 116)
Age (years) 52.1 ± 6.0 51.0 ± 5.5 51.5 ± 5.1 52.5 ± 4.8 0.205
Perimenopausal/postmenopausal (%) 40.3/59.7 49.1/50.9 46.5/53.5 41.4/58.6 0.455
Height (cm) 156.4 ± 5.6 158.1 ± 5.3 157.1 ± 5.4 155.5 ± 5.4 0.004
Body weight (kg) 53.0 ± 8.5 53.0 ± 8.7 54.1 ± 9.9 51.9 ± 9.4 0.337
Body mass index (kg · m–2) 21.6 ± 3.3 21.2 ± 3.3 21.9 ± 3.7 21.4 ± 3.6 0.491
Body fat (%) 26.7 ± 7.3 26.9 ± 8.4 27.6 ± 7.8 26.4 ± 7.8 0.806
Muscle mass (kg) 35.9 ± 2.7 36.0 ± 2.8 36.2 ± 3.4 35.3 ± 3.0 0.220
Water mass (kg) 27.5 ± 2.6 27.3 ± 2.9 27.8 ± 3.5 26.9 ± 2.8 0.211
Waist circumference (cm) 78.8 ± 9.0 77.2 ± 9.5 80.1 ± 9.8 77.6 ± 10.2 0.516
Hip circumference (cm) 92.0 ± 5.8 91.1 ± 6.2 91.5 ± 6.1 90.5 ± 7.2 0.295
Waist-hip ratio (%) 85.5 ± 6.0 84.5 ± 6.3 87.4 ± 6.4 85.6 ± 6.8 0.013
Systolic pressure (mmHg) 122.2 ± 14.5 124.1 ± 17.9 126.8 ± 14.9 127.7 ± 16.8 0.021
Diastolic pressure (mmHg) 78.5 ± 10.1 78.6 ± 12.2 81.8 ± 11.0 82.3 ± 11.6 0.007
Pulse rate (min–1) 61.7 ± 9.6 62.2 ± 8.0 64.2 ± 10.9 65.4 ± 12.6 0.015
Cardio-ankle vascular index 7.5 ± 0.8 7.5 ± 0.8 7.5 ± 0.8 7.5 ± 0.7 0.944
Daily alcohol consumption (%) 8.6 10.9 17.5 10.6 0.184
Smoking (%) 6.6 12.7 17.2 15.9 0.046
Regular exercise (%) 52.2 39.4 51.0 27.8 < 0.001
Data are expressed as mean ± standard deviation.
Statistical analyses were performed using one-way analysis of variance and chi-square tests.
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Table 4 Average physical and psychological symptom scores of the 4 clusters (N = 491)
CL8 CL6 CL5 CL4 P
(N = 162) (N = 111) (N = 102) (N = 116)
Physical health domain
Nausea 0.0 ± 0.2 0.3 ± 0.7 0.5 ± 1.0 0.6 ± 1.0 < 0.0001
Dizziness 0.2 ± 0.5 0.7 ± 0.9 0.6 ± 1.0 0.7 ± 1.0 < 0.0001
Numbness 0.4 ± 1.0 0.8 ± 1.1 0.8 ± 1.2 1.1 ± 1.3 < 0.0001
Muscle and joint pains 1.6 ± 1.2 2.3 ± 1.0 2.2 ± 1.1 2.3 ± 1.1 < 0.0001
Tiredness 1.0 ± 1.0 2.2 ± 0.9 2.0 ± 1.1 2.6 ± 0.9 < 0.0001
Headaches 0.4 ± 0.7 0.8 ± 1.0 1.0 ± 1.1 1.3 ± 1.2 < 0.0001
Frequent Urination 0.6 ± 1.0 0.9 ± 1.2 1.3 ± 1.3 1.3 ± 1.4 < 0.0001
Hot flush 0.5 ± 0.9 0.6 ± 0.9 2.1 ± 1.1 1.4 ± 1.2 < 0.0001
Night sweats 0.1 ± 0.4 0.2 ± 0.5 2.0 ± 1.1 1.3 ± 1.2 < 0.0001
Mental health domain
Loss of interest in things 0.1 ± 0.4 0.7 ± 0.9 0.7 ± 0.8 2.2 ± 1.1 < 0.0001
Lack of enjoyment 0.0 ± 0.2 0.8 ± 0.7 0.5 ± 0.6 2.6 ± 0.8 < 0.0001
Low energy 0.1 ± 0.3 1.3 ± 0.7 0.8 ± 0.8 2.8 ± 0.5 < 0.0001
Depressed mood 0.2 ± 0.4 1.5 ± 0.8 0.9 ± 0.8 2.9 ± 0.4 < 0.0001
Poor memory 0.8 ± 0.9 1.3 ± 1.0 1.3 ± 1.0 1.7 ± 1.1 < 0.0001
Difficulty in concentration 0.8 ± 0.9 1.3 ± 1.0 1.3 ± 1.0 1.7 ± 1.1 < 0.0001
Frightened/panicky feelings 0.3 ± 0.6 1.3 ± 1.0 1.1 ± 0.9 2.2 ± 1.0 < 0.0001
Feel tense/wound up 0.3 ± 0.6 0.8 ± 1.0 0.9 ± 1.1 1.8 ± 1.2 < 0.0001
Dissatisfaction with sexual relationship 0.1 ± 0.5 0.3 ± 0.7 0.4 ± 0.9 0.4 ± 0.9 0.0134
Difficulty in initiating sleep 0.4 ± 0.7 0.8 ± 1.0 1.6 ± 1.2 1.7 ± 1.3 < 0.0001
Non-restorative sleep 0.5 ± 0.9 1.3 ± 1.2 1.7 ± 1.2 2.0 ± 1.1 < 0.0001
Low self-esteem 0.5 ± 0.8 1.4 ± 1.2 1.1 ± 1.1 2.1 ± 1.2 < 0.0001
Data are expressed as mean ± standard deviation.
Statistical analyses were performed using the Kruskal-Wallis test.
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In this study, we analyzed the responses to 9 physical
and 12 psychological items on the Menopausal Health-
Related Quality of Life questionnaire by 491 Japanese
women attending our menopause clinic aged 40–64
years. The first analysis extracted 3 PCs (depression,
somatic, and vasomotor/sleep) that defined the variance
of physical and psychological symptom profiles of the
women. A subsequent cluster analysis was performed
based on the 3 PCs to generate 4 clusters: CL8, CL6,
CL5, and CL4. CL8 was composed of women who had
only mild-to-moderate musculoskeletal pains and tired-
ness. All women in CL6, CL5, and CL4 described their
musculoskeletal pains and tiredness as moderate to se-
vere. The women in CL5 also had moderate-to-severe
vasomotor symptoms, while the women in CL4 also suf-
fered from moderate-to-severe psychological symptoms,
such as depression, anxiety, and insomnia.
Many previous studies have categorized menopausal
symptoms of non-menopause clinic samples and popula-
tion based samples, and identified subgroups of women inthe menopausal transition on the basis of their responses
to symptom checklists. In 1986, Hunter et al. first intro-
duced their “Women’s Health Questionnaire”, and they
performed a PCA of responses to the 36-item symptom
checklist among 682 English women attending an ovarian
screening program aged 45–65 years [1]. Based on the
analysis, they defined 9 symptom clusters, namely “somatic
symptoms”, “depressed mood”, “cognitive difficulties”,
“anxiety/fears”, “sexual functioning”, “vasomotor symp-
toms”, “sleep problems”, “menstrual”, and “attractive”.
Similar studies using PCA methods have been per-
formed to identify menopausal symptom clusters specific
to Hong Kong Chinese [2] and Taiwanese [3]; to examine
cross-cultural variation among the United States, Spain,
Lebanon, and Morocco [4]; to investigate how symptoms
cluster across menopausal transition stages [5]; and to
determine which symptom cluster has the greatest effect
on quality of life [6]. In a random telephone survey of
Hong Kong Chinese women, Ho et al. identified 5 symp-
tom clusters: psychological, musculoskeletal/gastrointes-
tinal, non-specific somatic, respiratory, and vasomotor
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et al. identified 4 symptom clusters: musculoskeletal,
non-specific somatic complaints, urogenital, and vaso-
motor [3]. Sievert et al. showed in their study of general
population that the inter-correlation among symptoms
differed in country-specific ways; for example, hot flush
grouped with vaginal dryness and sexual symptoms in
Spain, with general somatic symptoms in Morocco, and
did not cluster with other symptoms in the United States
or Lebanon [4]. Based on the observations from the
Seattle Midlife Women’s Health Study (SMWHS), Cray
et al. revealed similar factor structures across the 4 meno-
pausal transition stages (late reproductive, early or late
menopausal transition, or early postmenopause) in that
each stage revealed a mood component, a vasomotor com-
ponent, and a pain component [5]. A study by Greenblum
et al. identified 3 symptom clusters in middle-aged Floridian
community-dwelling women: (1) anxiety, irritability, and fa-
tigue; (2) weight gain and urinary stress incontinence; and
(3) vaginal dryness and sleep disturbances, which had the
greatest impact on quality of life [6].
A different approach using cluster analysis was taken
to investigate the relationships between patterns of de-
pressed mood and menopausal transition stages [19] or
to identify clusters of female urological symptoms [20].
Using the data from SMWHS, Woods et al. revealed that
the majority of women experienced the menopausal
transition without a high severity of depressed mood,
while a small group of women had mood worsening over
time and others improved [19]. Hall et al. conducted a
cluster analysis of urological symptoms among women
in the Boston Area Community Health Survey and iden-
tified 4 clusters, which were distinguished by the severity
of storage symptoms, frequency symptoms, urinary in-
continence, and interference [20].
Recently, Cray et al. introduced latent class analysis to
identify subgroups of women in the menopausal transi-
tion stage that experienced the same cluster of represen-
tative symptoms [7,8]. They first selected 5 symptoms
based on PCA of the SMWHS participants’ responses to
the 47-item symptom checklist: sleep, pain, mood, cog-
nitive, and tension. Multilevel latent class analysis using
scores for hot flush and these 5 symptoms identified 3
classes: low severity levels for all symptoms; low severity
hot flush and moderate severity levels for all other
symptom factors; high severity hot flush with lower se-
verity levels of all other symptom factors. In their most
recent report, Woods et al. identified several endocrine
biomarkers associated with the distinction among the
subgroups, including estrogen, follicle stimulating hor-
mone, epinephrine, and norepinephrine [21].
Similar to our findings, a 2013 SMWHS report by Cray
et al. identified 3 major components of symptoms identi-
fied by PCA [5]. These included psychological, vasomotor,and musculoskeletal pains, of which the psychological
component accounted for more than 30% of variance of
the profile of menopausal symptoms. Cross-cultural diver-
sity in menopausal symptomatology has been frequently
demonstrated [22], and fewer Asian women have been
shown to report vasomotor and other menopausal symp-
toms compared with their Caucasoid counterparts [23];
nevertheless, these fundamental components might be
similar between the United States and Japan.
One of the major limitations of our study was that the
participants were recruited in a clinical setting, and the
results were not necessarily representative of the general
population of Japan. Nevertheless, the findings of the
current study are relevant to clinical practice as they ad-
dress the complex symptomatology in women attending
a menopause clinic.
Conclusions
In conclusion, distinct subgroups of Japanese perimeno-
pausal and postmenopausal women were identified based
on the severity of depression, somatic, and vasomotor/
sleep symptoms. This subgrouping of women revealed
that menopausal symptoms accumulate in this population
in the order of musculoskeletal pains, vasomotor symp-
toms, and psychological symptoms.
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